Projects per year
Personal profile
Education
- 2008 Ph.D Rutgers UniversityPharmacology
- 1998 M.S., Institute of Biochemistry and Molecular Biology
- 1996 B.S., Department of Agriculture Chemistry, National Taiwan University
Experience
- 2018- Assiociate Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2018- Assiociate Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2013-2018 Assistant Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2009-2013 Postdoc, Princeton University
Research Interests
- DNA damage
- tumor biology
- vaccine design
URL
Fingerprint Dive into the research topics where Yuan-Chin Tsai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 6 Finished
Studies of Prostate Cancer Progression after Androgen-Deprivation Therapy and Development of Cancer Immunotherapy via Anti-Inflammation Approaches
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
Roles of Microrna96 in Tgfβ-Mediated Tumor Progression
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
探討microRNA96在轉化生長因子β導致的癌症演進過程的角色(2/3)
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
Roles of microRNA96 in TGF-beta-Mediated Tumor Progression
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
TMU102-AE1-B30
4/1/14 → 12/31/16
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
Research Output
Tumor-infiltrating leukocytes suppress local inflammation via interleukin-1 receptor antagonist in a syngeneic prostate cancer model
Fan, Y. C., Chen, W. Y., Lee, K. D. & Tsai, Y. C., Apr 2020, In : Biology. 9, 4, 67.Research output: Contribution to journal › Article
Open Access
Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
Tsai, Y. C., Chen, W. Y., Abou-Kheir, W., Zeng, T., Yin, J. J., Bahmad, H., Lee, Y. C. & Liu, Y. N., May 1 2018, In : Biochimica et Biophysica Acta - Molecular Basis of Disease. 1864, 5, p. 1717-1727 11 p.Research output: Contribution to journal › Article
8
Citations
(Scopus)
A synergistic anti-cancer effect of troglitazone and lovastatin in a human anaplastic thyroid cancer cell line and in a mouse xenograft model
Zhong, W. B., Tsai, Y. C., Chin, L. H., Tseng, J. H., Tang, L. W., Horng, S., Fan, Y. C. & Hsu, S. P., Jul 1 2018, In : International Journal of Molecular Sciences. 19, 7, 1834.Research output: Contribution to journal › Article
6
Citations
(Scopus)
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. C., Zeng, T., Abou-Kheir, W., Yeh, H. L., Yin, J. J., Lee, Y. C., Chen, W. Y. & Liu, Y. N., Feb 19 2018, In : Molecular Cancer. 17, 1, 42.Research output: Contribution to journal › Article
1
Citation
(Scopus)
Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6
Tsai, Y. C., Chen, W. Y., Siu, M. K., Tsai, H. Y., Yin, J. J., Huang, J. & Liu, Y. N., Jan 1 2017, In : Cancer Letters. 384, p. 1-8 8 p.Research output: Contribution to journal › Article
12
Citations
(Scopus)